Overview

• BIO touched a six-month high of $0.1514 before easing toward $0.138, with daily gains around 25% and an intraday jump near 50% reported by different outlets.
• 24-hour trading volume jumped by roughly 720% last week to over $400 million, lifting liquidity and market interest.
• Cerebrum DAO approved $80,000 to expand a human trial for the Percepta brain health supplement, with Bio Protocol receiving CLAW tokens tied to product royalties.
• Staked BIO rose to about 125 million, roughly 3.5% of the circulating supply, generating BioXP for ecosystem access and reducing liquid supply.
• Bio Protocol launched Bio Markets to provide real-time DeSci analytics and in-app trading for BioDAOs, with plans to extend trading to IP‑Tokens and BioAgents.